Description: HEDQIN is the fixed dose combination therapy of Dihydroartemisinin & Piperaquine Phosphate used as first-line treatment of uncomplicated malaria. Dihydroartemisinin is the most active metabolite of all artemisinin compounds and Piperaquine Phosphate belongs to the 4-amino- quinoline.
Indication: World Health Organization (WHO) strongly recommends Dihydroartemisinin + Piperaquine Phosphate (HEDQIN) as a latest ACT option to use as first line treatment for the uncomplicated P. falciparum malaria including multi-drug resistant strains. Dihydroartemisinin + Piperaquine Phosphate is also effective against P. vivax malaria and has strong action on gametocytes. Piperaquine is also used as prophylaxis due to the advantage of its longer half life.